Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Investor Overview

Corporate Profile

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.


Toggle Summary Stryker completes acquisition of K2M
Kalamazoo, Michigan , Nov. 09, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) has completed the previously announced acquisition of K2M Group Holdings, Inc. , a global leader of complex spine and minimally invasive solutions. "K2M's broad product portfolio and robust pipeline complement Stryker’s
Toggle Summary Stryker reports third quarter 2018 operating results
Reported net sales increased 7.9% to $3.2 billion Organic net sales increased 7.9% Reported operating income margin of 17.8% Adjusted operating income margin (1) expanded 60 bps (40 bps excluding ASC 606 (2) ) to 24.9% Reported EPS increased 36.0% to $1.55 Adjusted EPS (3) increased 11.2% to $1.69
Toggle Summary Stryker completes acquisition of Invuity, Inc.
Kalamazoo, Michigan - October 23, 2018 - Stryker (NYSE:SYK) announced today the completion of its previously announced acquisition of Invuity, Inc.  Invuity is the leader in advanced photonics and single-use, lighted instruments that deliver enhanced visualization for a wide variety of clinical
Toggle Summary Stryker to host analyst meeting
Kalamazoo, Michigan - October 4, 2018 - Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 8, 2018 , at 2:30 p.m. Eastern Time , in Mahwah, New Jersey.  A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at


There are currently no events to display.
Investor Contacts
Katherine A. Owen
Vice President, Strategy & Investor Relations
2825 Airview Boulevard
Kalamazoo, MI 49002